Observational study of first-line therapy including cetuximab in patients with metastatic colorectal cancer

Trial Profile

Observational study of first-line therapy including cetuximab in patients with metastatic colorectal cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Jun 2016

At a glance

  • Drugs Cetuximab (Primary) ; Antineoplastics
  • Indications Colorectal cancer
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms CORAL
  • Most Recent Events

    • 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology.
    • 17 Aug 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 18 Jan 2014 Interim results presented at the 2014 Gastrointestinal Cancers Symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top